No profile data available.
Femasys Inc. (FEMY) is a healthcare company in the targeted healthcare equipment industry, based in Suwanee, United States, with about 51 full-time employees.
It reported revenue of $2.29 million for fiscal year 2025, up 40.8% from fiscal year 2024, and net income of -$18.63 million. In Q2 2026 (the quarter ended June 30, 2026) revenue was $331,827, down 18.9% from a year before. United States was its largest region in fiscal year 2025, with 61% of revenue. Its market capitalization was $16.75 million as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of October 9, 2026.
, a biomedical company, develops and commercializes therapeutic and diagnostic products for women's reproductive health needs in the United States and internationally.
Femasys reported $2.29 million in revenue for fiscal year 2025, up 40.8% from $1.63 million in fiscal year 2024. In Q2 2026 revenue was $331,827.
United States: 61% of revenue by region in fiscal year 2025, followed by International (39%).
$16.75 million as of October 9, 2026.
Listed companies of a similar size in the same industry (targeted healthcare equipment) include Firefly Neuroscience, Inc. (AIFF), Nexalin Technology, Inc. (NXL), Guided Therapeutics, Inc. (GTHP), Iridex Corporation (IRIX).